Patent · US Active

Estrogen sensing through GPER1 regulates normal and malignant liver growth

US11040054B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

The Brigham and Women's Hospital, Inc. · US

Inventors

Wolfram Goessling · Sharon, US
Saireudee Chaturantabut · Boston, US

Key dates

Filing date	Nov 14, 2017
Grant date	Jun 22, 2021
Priority date	—
Expiry date	Nov 14, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods for the prevention and treatment of an abnormal tissue condition in the liver (e.g., liver cancer) of a subject, based on the administration of an inhibitor of a G protein-coupled estrogen receptor 1 (GPER1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.